Clinical trial
Evaluation of Single Session Stereotactic Body Radiotherapy
NCT00492817 · M.D. Anderson Cancer Center, Other · Completed
Key facts
| NCT number | NCT00492817 |
|---|---|
| Title | Evaluation of Single Session Stereotactic Body Radiotherapy |
| Official title | Phase I/II Evaluation of Single Session Stereotactic Body Radiotherapy for Spinal or Paraspinal Metastases |
| Lead sponsor | M.D. Anderson Cancer Center, Other |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Spinal Neoplasms |
| Intervention type | Procedure |
| Interventions | Stereotactic Body Radiotherapy |
| Enrollment | 71 |
| Start date | Oct 13, 2005 |
| Primary completion | Nov 27, 2024 |
| Completion | Nov 27, 2024 |
| First posted | Jun 27, 2007 |
| Last update posted | Oct 24, 2025 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: